Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RYLPF declined for three days, in of 156 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RYLPF as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
RYLPF broke above its upper Bollinger Band on November 29, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RYLPF entered a downward trend on December 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for RYLPF just turned positive on November 27, 2024. Looking at past instances where RYLPF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.437) is normal, around the industry mean (23.300). P/E Ratio (29.762) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (2.819) is also within normal values, averaging (5.667). Dividend Yield (0.043) settles around the average of (0.018) among similar stocks. P/S Ratio (0.951) is also within normal values, averaging (43.338).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RYLPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYLPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GRGUX | 48.19 | N/A | N/A |
Goldman Sachs Equity Income R6 | |||
MSEEX | 22.48 | -0.03 | -0.13% |
Morgan Stanley Europe Opportunity C | |||
BALFX | 35.05 | -0.19 | -0.54% |
American Funds American Balanced F1 | |||
ISMOX | 4.30 | -0.03 | -0.69% |
Voya MidCap Opportunities Port S | |||
DEVIX | 72.37 | -1.10 | -1.50% |
Delaware Small Cap Value Instl |
A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with PHG. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then PHG could also see price increases.
Ticker / NAME | Correlation To RYLPF | 1D Price Change % | ||
---|---|---|---|---|
RYLPF | 100% | N/A | ||
PHG - RYLPF | 56% Loosely correlated | -2.53% | ||
MBGNF - RYLPF | 24% Poorly correlated | N/A | ||
SNNUF - RYLPF | 21% Poorly correlated | N/A | ||
RDGL - RYLPF | 8% Poorly correlated | -5.36% | ||
RSCF - RYLPF | 5% Poorly correlated | -0.23% | ||
More |